It has been reported that the polymorphism of ACE2 seriously affects the pathogenesis and spread of COVID-19, and the binding affinity between ACE2 and RBD can be effectively regulated by targeting mutations at multiple interfaces of ACE2 [74,75]. The gene discussed is ACE2; the disease is COVID-19.